United Therapeutics Corporation

Historical 13F Holders

Symbol
UTHR
CUSIP
91307C102
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 194 8.52 M $2.62 B
2024 Q4 693 44.1 M $15.5 B
2024 Q3 643 43.6 M $15.6 B
2024 Q2 594 47.0 M $15.0 B
2024 Q1 548 45.9 M $10.6 B
2023 Q4 550 45.4 M $9.97 B
2023 Q3 534 44.4 M $10.0 B
2023 Q2 499 45.0 M $9.92 B
2023 Q1 525 45.7 M $10.1 B
2022 Q4 533 46.5 M $12.9 B
2022 Q3 481 45.6 M $9.56 B
2022 Q2 490 44.1 M $10.4 B
2022 Q1 448 44.1 M $7.91 B
2021 Q4 438 43.2 M $9.34 B
2021 Q3 443 44.2 M $8.15 B
2021 Q2 420 44.1 M $7.91 B
2021 Q1 415 43.6 M $7.31 B
2020 Q4 385 44.1 M $6.71 B
2020 Q3 353 42.1 M $4.26 B
2020 Q2 375 42.5 M $5.14 B
2020 Q1 328 43.1 M $4.08 B
2019 Q4 343 41.9 M $3.69 B
2019 Q3 331 41.8 M $3.33 B
2019 Q2 356 42.2 M $3.29 B
2019 Q1 402 42.9 M $5.02 B
2018 Q4 380 44.1 M $4.78 B
2018 Q3 389 44.1 M $5.62 B
2018 Q2 396 42.9 M $4.85 B
2018 Q1 395 43.8 M $4.91 B
2017 Q4 422 44.6 M $6.56 B
2017 Q3 403 43.7 M $5.13 B
2017 Q2 399 46.3 M $6.01 B
2017 Q1 438 49.8 M $6.75 B
2016 Q4 434 48.0 M $6.87 B
2016 Q3 422 48.8 M $5.75 B
2016 Q2 412 49.6 M $5.25 B
2016 Q1 424 51.2 M $5.70 B
2015 Q4 415 51.6 M $8.08 B
2015 Q3 391 51.0 M $6.70 B
2015 Q2 409 51.0 M $8.87 B
2015 Q1 387 52.4 M $9.03 B
2014 Q4 351 51.6 M $6.69 B
2014 Q3 340 53.1 M $9.17 B
2014 Q2 317 53.6 M $4.75 B
2014 Q1 328 67.6 M $7.83 B